Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Study of Leukocyte Responses in the Blood of Patients With Leptospirosis and ex Vivo Testing of a New Host-targeted Therapeutic Strategy to Restore Phagocytosis of Leptospira

NCT07611591 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.

NCT NCT07611591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07611591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Study of Leukocyte Responses in the Blood of Patients With Leptospirosis and ex Vivo Testing of a New Host-targeted Therapeutic Strategy to Restore Phagocytosis of Leptospira
Lead sponsor
Institut Pasteur
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
July 1, 2029
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

jarisch herxheimer reaction, leptospirosis